Eczema Awareness Monthly – An American Academy of Dermatology Official Licensee
0
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
0
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Advertisement

Studies

Phosphodiesterase 4 inhibitors a promising alternative to topical corticosteroids

Historically, atopic dermatitis (AD) has been treated with ...

Posted by by Awareness Monthly
READ MORE

Analysis of 2001-2013 Medical Expenditure Panel Survey explores racial and ethnic differences in health care utilization for childhood eczema

Past studies have suggested differences in prevalence and ...

Posted by by Awareness Monthly
READ MORE

Lebrikizumab, with topical corticosteroid treatment, successful in atopic dermatitis

A recent phase II study on the efficacy ...

Posted by by Awareness Monthly
READ MORE

Fezakinumab in phase 2a trial for adults with moderate-to-severe atopic dermatitis

A phase 2a trial was recently conducted to ...

Posted by by Awareness Monthly
READ MORE
1 … 9 10
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee

© 2020-2023 Powered by eHealthcare Solutions | Privacy Policy

×